Form 8-K - Current report:
SEC Accession No. 0001213900-25-085213
Filing Date
2025-09-08
Accepted
2025-09-05 19:25:38
Documents
15
Period of Report
2025-09-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0256293-8k_inmed.htm   iXBRL 8-K 41844
2 NEWS RELEASE, DATED SEPTEMBER 5, 2025 ea025629301ex99-1_inmed.htm EX-99.1 9404
3 GRAPHIC ex99-1_001.jpg GRAPHIC 16114
  Complete submission text file 0001213900-25-085213.txt   269382

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20250905.xsd EX-101.SCH 3020
5 XBRL DEFINITION FILE inm-20250905_def.xml EX-101.DEF 26194
6 XBRL LABEL FILE inm-20250905_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE inm-20250905_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0256293-8k_inmed_htm.xml XML 3680
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 251298298
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)